Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand

Journal of Virology

Volumn 84, Issue 6, 2010, Pages 2762-2773

  Chehimi, Jihed ^a   Papasavvas, Emmanouil ^a   Tomescu, Costin ^a   Gekonge, Bethsebah ^a   Abdulhaqq, Shaheed ^a   Raymond, Andrea ^a   Hancock, Aidan ^a   Vinekar, Kavita ^a   Carty, Craig ^b   Reynolds, Griffin ^a   Pistilli, Maxwell ^a   Mounzer, Karam ^c   Kostman, Jay ^b   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Philadelphia Fight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; BETA INTERFERON; DEATH RECEPTOR 5; INTERFERON REGULATOR FACTOR 7; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REBOUND; T LYMPHOCYTE ACTIVATION; TREATMENT WITHDRAWAL; VIREMIA; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND; VIRAL LOAD; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77649111284     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01350-09     Document Type: Article

References (74)

1. Argyris, E. G., E. Acheampong, F. Wang, J. Huang, K. Chen, M. Mukhtar, and H. Zhang. 2007. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. Virology 367:440-451.
2. Audige, A., M. Urosevic, E. Schlaepfer, R. Walker, D. Powell, S. Hallenberger, H. Joller, H. U. Simon, R. Dummer, and R. F. Speck. 2006. Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. J. Immunol. 177:6227-6237.
3. Beignon, A. S., K. McKenna, M. Skoberne, O. Manches, I. DaSilva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, and N. Bhardwaj. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Investig. 115:3265-3275.
4. Biancotto, A., J. C. Grivel, S. J. Iglehart, C. Vanpouille, A. Lisco, S. F. Sieg, R. Debernardo, K. Garate, B. Rodriguez, L. B. Margolis, and M. M. Lederman. 2007. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109:4272-4279.
5. Boasso, A., J. P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer. 2007. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109:3351-3359.
6. Brown, K. N., A. Trichel, and S. M. Barratt-Boyes. 2007. Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS. J. Immunol. 178:6958-6967.
7. Budd, R. C. 2002. Death receptors couple to both cell proliferation and apoptosis. J. Clin. Investig. 109:437-441.
8. Capobianchi, M. R., F. De Marco, P. Di Marco, and F. Dianzani. 1988. Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells. Arch. Virol. 99:9-19.
9. Chaperot, L., A. Blum, O. Manches, G. Lui, J. Angel, J. P. Molens, and J. Plumas. 2006. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176:248-255.
10. Chehimi, J., L. Azzoni, M. Farabaugh, S. A. Creer, C. Tomescu, A. Hancock, A. Mackiewicz, L. D'Alessandro, S. Ghanekar, A. S. Foulkes, K. Mounzer, J. Kostman, and L. J. Montaner. 2007. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment. J. Immunol. 179:2642-2650.
11. Chehimi, J., D. E. Campbell, L. Azzoni, D. Bacheller, E. Papasavvas, G. Jerandi, K. Mounzer, J. Kostman, G. Trinchieri, and L. J. Montaner. 2002. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J. Immunol. 168:4796-4801.
12. Chehimi, J., S. E. Starr, I. Frank, M. Rengaraju, S. J. Jackson, C. Llanes, M. Kobayashi, B. Perussia, D. Young, E. Nickbarg, et al. 1992. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:789-796.
13. Clerici, M., and G. M. Shearer. 1993. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
14. Conry, S. J., K. A. Milkovich, N. L. Yonkers, B. Rodriguez, H. B. Bernstein, R. Asaad, F. P. Heinzel, M. Tary-Lehmann, M. M. Lederman, and D. D. Anthony. 2009. Impaired PDC-NK activity in viremic HIV infection attributable to impairments in both PDC and NK function. J. Virol. 83:11175-11187.
15. Dai, J., N. J. Megjugorac, S. B. Amrute, and P. Fitzgerald-Bocarsly. 2004. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J. Immunol. 173:1535-1548.
16. Danis, B., T. C. George, S. Goriely, B. Dutta, J. Renneson, L. Gatto, P. Fitzgerald-Bocarsly, A. Marchant, M. Goldman, F. Willems, and D. De Wit. 2008. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur. J. Immunol. 38:507-517.
17. Di Domizio, J., A. Blum, M. Gallagher-Gambarelli, J. P. Molens, L. Chaperot, and J. Plumas. 2009. TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. Blood 114:1794-1802.
18. Dillon, S. M., K. B. Robertson, S. C. Pan, S. Mawhinney, A. L. Meditz, J. M. Folkvord, E. Connick, M. D. McCarter, and C. C. Wilson. 2008. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J. Acquir Immune Defic. Syndr. 48:1-12.
19. Diop, O. M., M. J. Ploquin, L. Mortara, A. Faye, B. Jacquelin, D. Kunkel, P. Lebon, C. Butor, A. Hosmalin, F. Barre-Sinoussi, and M. C. Muller-Trutwin. 2008. Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome. J. Virol. 82:5145-5152.
20. Ehrhard, S., M. Wernli, G. Kaufmann, G. Pantaleo, G. P. Rizzardi, F. Gudat, P. Erb, and M. Battegay. 2008. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals. Infection 36:120-129.
21. Ehrhardt, H., S. Fulda, I. Schmid, J. Hiscott, K. M. Debatin, and I. Jeremias. 2003. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene 22:3842-3852.
22. Emilie, D., M. Peuchmaur, M. C. Maillot, M. C. Crevon, N. Brousse, J. F. Delfraissy, J. Dormont, and P. Galanaud. 1990. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Investig. 86:148-159.
23. Fauci, A. S. 1993. Immunopathogenesis of HIV infection. J. Acquir Immune Defic. Syndr. 6:655-662.
24. Feldman, S., D. Stein, S. Amrute, T. Denny, Z. Garcia, P. Kloser, Y. Sun, N. Megjugorac, and P. Fitzgerald-Bocarsly. 2001. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol. 101:201-210.
25. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129-134.
26. Fitzgerald-Bocarsly, P., J. Dai, and S. Singh. 2008. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 19:3-19.
27. Fitzgerald-Bocarsly, P., and D. Feng. 2007. The role of type I interferon production by dendritic cells in host defense. Biochimie 89:843-855.
28. Fonteneau, J. F., M. Larsson, A. S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y. J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78:5223-5232.
29. Gendelman, H. E., R. M. Friedman, S. Joe, L. M. Baca, J. A. Turpin, G. Dveksler, M. S. Meltzer, and C. Dieffenbach. 1990. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 172:1433-1442.
30. Gendelman, H. E., R. M. Friedman, S. Joe, L. M. Baca, J. A. Turpin, G. Dveksler, M. S. Meltzer, and C. Dieffenbach. 1991. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 173:277.
31. George, T. C., P. J. Morrissey, C. Cui, S. Singh, and P. F. Bocarsly. 2009. Measurement of cytoplasmic to nuclear translocation. Curr. Protoc. Cytom., chapter 9, unit 9.28.
32. Goila-Gaur, R., and K. Strebel. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5:51.
33. Gougeon, M. L. 2003. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3:392-404.
34. Gougeon, M. L. 2004. Apoptotic pathways triggered by HIV and consequences on T cell homeostasis and HIV-specific immunity. Prog. Mol. Subcell. Biol. 36:95-115.
35. Gurney, K. B., A. D. Colantonio, B. Blom, H. Spits, and C. H. Uittenbogaart. 2004. Endogenous IFN-alpha production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection. J. Immunol. 173:7269-7276.
36. Hansjee, N., G. R. Kaufmann, C. Strub, R. Weber, M. Battegay, and P. Erb. 2004. Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes. J. Acquir Immune Defic. Syndr. 36:671-677.
37. Hardy, A. W., D. R. Graham, G. M. Shearer, and J. P. Herbeuval. 2007. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc. Natl. Acad. Sci. U. S. A. 104:17453-17458.
38. Herbeuval, J. P., J. C. Grivel, A. Boasso, A. W. Hardy, C. Chougnet, M. J. Dolan, H. Yagita, J. D. Lifson, and G. M. Shearer. 2005. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 106:3524-3531.
39. Herbeuval, J. P., A. W. Hardy, A. Boasso, S. A. Anderson, M. J. Dolan, M. Dy, and G. M. Shearer. 2005. Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 102:13974-13979.
40. Herbeuval, J. P., J. Nilsson, A. Boasso, A. W. Hardy, M. J. Kruhlak, S. A. Anderson, M. J. Dolan, M. Dy, J. Andersson, and G. M. Shearer. 2006. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl. Acad. Sci. U. S. A. 103:7000-7005.
41. Herbeuval, J. P., J. Nilsson, A. Boasso, A. W. Hardy, M. Vaccari, V. Cecchinato, V. Valeri, G. Franchini, J. Andersson, and G. M. Shearer. 2009. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. AIDS 23:35-40.
42. Herbeuval, J. P., and G. M. Shearer. 2007. HIV-1 immunopathogenesis: how good interferon turns bad. Clin. Immunol. 123:121-128.
43. Hietakangas, V., M. Poukkula, K. M. Heiskanen, J. T. Karvinen, L. Sistonen, and J. E. Eriksson. 2003. Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol. Cell. Biol. 23:1278-1291.
44. Holmes, R. K., F. A. Koning, K. N. Bishop, and M. H. Malim. 2007. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 282:2587-2595.
45. Honda, K., Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, C. Taya, and T. Taniguchi. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434:1035-1040.
46. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777.
47. Hosmalin, A., and P. Lebon. 2006. Type I interferon production in HIV-infected patients. J. Leukoc. Biol. 80:984-993.
48. Kim, N., A. Dabrowska, R. G. Jenner, and A. Aldovini. 2007. Human and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species. J. Virol. 81:7584-7597.
49. Lapenta, C., S. M. Santini, E. Proietti, P. Rizza, M. Logozzi, M. Spada, S. Parlato, S. Fais, P. M. Pitha, and F. Belardelli. 1999. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells. Virology 263:78-88.
50. Levina, V., A. M. Marrangoni, R. DeMarco, E. Gorelik, and A. E. Lokshin. 2008. Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production. Exp. Cell Res. 314:1605-1616.
51. Levy, J. A. 1993. HIV and host immune responses in AIDS pathogenesis. J. Clin. Apher. 8:19-28.
52. Levy, J. A. 2006. HIV pathogenesis: knowledge gained after two decades of research. Adv. Dent. Res. 19:10-16.
53. Manches, O., D. Munn, A. Fallahi, J. Lifson, L. Chaperot, J. Plumas, and N. Bhardwaj. 2008. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J. Clin. Invest. 118:3431-3439.
54. Martinelli, E., C. Cicala, D. Van Ryk, D. J. Goode, K. Macleod, J. Arthos, and A. S. Fauci. 2007. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 104:3396-3401.
55. McCune, J. M. 2001. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410:974-979.
56. Megjugorac, N. J., E. S. Jacobs, A. G. Izaguirre, T. C. George, G. Gupta, and P. Fitzgerald-Bocarsly. 2007. Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSV-infected monocyte-derived dendritic cells. Immunol. Invest. 36:739-761.
57. Meyers, J. H., J. S. Justement, C. W. Hallahan, E. T. Blair, Y. A. Sun, M. A. O'Shea, G. Roby, S. Kottilil, S. Moir, C. M. Kovacs, T. W. Chun, and A. S. Fauci. 2007. Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells. PLoS One 2:e458.
58. Muller-Trutwin, M., and A. Hosmalin. 2005. Role for plasmacytoid dendritic cells in anti-HIV innate immunity. Immunol. Cell Biol. 83:578-583.
59. Neumann, A., M. Polis, L. Rozenberg, J. Jackson, K. Reitano, M. McLaughlin, C. Koratich, R. Dewar, H. Masur, B. Haagmans, and S. Kottilil. 2007. Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients. AIDS 21:1855-1865.
60. Papasavvas, E., J. R. Kostman, K. Mounzer, R. M. Grant, R. Gross, C. Gallo, L. Azzoni, A. Foulkes, B. Thiel, M. Pistilli, A. Mackiewicz, J. Shull, and L. J. Montaner. 2004. Randomized, controlled trial of therapy interruption in chronic HIV-1 infection. PLoS Med. 1:e64.
61. Quaranta, M. G., A. Napolitano, M. Sanchez, L. Giordani, B. Mattioli, and M. Viora. 2007. HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets. FASEB J. 21:2323-2334.
62. Reitano, K. N., S. Kottilil, C. M. Gille, X. Zhang, M. Yan, M. A. O'Shea, G. Roby, C. W. Hallahan, J. Yang, R. A. Lempicki, J. Arthos, and A. S. Fauci. 2009. Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. AIDS Res. Hum. Retroviruses 25:1029-1037.
63. Rodriguez, B., M. M. Lederman, W. Jiang, D. A. Bazdar, K. Garate, C. V. Harding, and S. F. Sieg. 2006. Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection. AIDS 20:1379-1389.
64. Secchiero, P., A. Gonelli, E. Carnevale, D. Milani, A. Pandolfi, D. Zella, and G. Zauli. 2003. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107:2250-2256.
65. Shepard, B. D., D. De Forni, D. R. McNamara, A. Foli, S. A. Rizza, R. S. Abraham, K. Knutson, P. J. Wettstein, F. Lori, and A. D. Badley. 2008. Beneficial effect of TRAIL on HIV burden, without detectable immune consequences. PLoS One 3:e3096.
66. Siegal, F. 2003. Interferon-producing plasmacytoid dendritic cells and the pathogenesis of AIDS. Res. Initiat. Treat. Action 8:10-13.
67. Soumelis, V., I. Scott, F. Gheyas, D. Bouhour, G. Cozon, L. Cotte, L. Huang, J. A. Levy, and Y. J. Liu. 2001. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98:906-912.
68. Stary, G., I. Klein, S. Kohlhofer, F. Koszik, T. Scherzer, L. Mullauer, H. Quendler, N. Kohrgruber, and G. Stingl. 2009. Plasmacytoid dendritic cells express TRAIL and induce CD4+ T cell apoptosis in HIV-1 viremic patients. Blood 114:3854-3863.
69. Swindells, S., T. Baldwin, C. Kelly, L. Baca-Regen, L. Loomis, D. Post, B. Brichacek, M. Stevenson, E. A. Dominguez, R. Reddy, R. Klein, M. J. Liao, D. Testa, T. McDonald, J. Bellanti, S. Skurkovich, and H. E. Gendelman. 1996. Regulation and characterization of the interferon-alpha present in patients with advanced human immunodeficiency virus type 1 disease. J. Interferon Cytokine Res. 16:127-137.
70. Takeuchi, H., and T. Matano. 2008. Host factors involved in resistance to retroviral infection. Microbiol. Immunol. 52:318-325.
71. Tilton, J. C., M. M. Manion, M. R. Luskin, A. J. Johnson, A. A. Patamawenu, C. W. Hallahan, N. A. Cogliano-Shutta, J. M. Mican, R. T. Davey, Jr., S. Kottilil, J. D. Lifson, J. A. Metcalf, R. A. Lempicki, and M. Connors. 2008. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J. Virol. 82:3997-4006.
72. Tomescu, C., J. Chehimi, V. C. Maino, and L. J. Montaner. 2007. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. J. Immunol. 179:2097-2104.
73. Vilimanovich, U., and V. Bumbasirevic. 2008. TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2. Cell. Mol. Life Sci. 65:814-826.
74. Zagury, D., H. Lecoq, I. Gervi, H. Le Buanec, J. F. Zagury, B. Bizzini, A. Burny, P. Hermans, M. Perja, E. Santagostino, and A. Gringeri. 1999. Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum-an adjuvant to antiretroviral tritherapy. Biomed. Pharmacother. 53: 90-92.